These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26104907)

  • 1. To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.
    Koff JL; Chihara D; Phan A; Nastoupil LJ; Williams JN; Flowers CR
    Curr Hematol Malig Rep; 2015 Sep; 10(3):244-55. PubMed ID: 26104907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BC; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami HO; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):130-44. PubMed ID: 25174034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.
    Chihara D; Nastoupil LJ; Williams JN; Lee P; Koff JL; Flowers CR
    Expert Rev Anticancer Ther; 2015 May; 15(5):531-44. PubMed ID: 25864967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
    Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
    Glass S; Phan A; Williams JN; Flowers CR; Koff JL
    Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.
    Simard JF; Baecklund F; Chang ET; Baecklund E; Hjalgrim H; -Olov Adami H; Glimelius B; Smedby KE
    Int J Cancer; 2013 Jun; 132(11):2659-66. PubMed ID: 23160780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and etiology of non-hodgkin lymphoma.
    Chiu BC; Hou N
    Cancer Treat Res; 2015; 165():1-25. PubMed ID: 25655604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
    't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A
    Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update of the epidemiology of non-Hodgkin's lymphoma.
    Chiu BC; Weisenburger DD
    Clin Lymphoma; 2003 Dec; 4(3):161-8. PubMed ID: 14715098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity and the risk of non-Hodgkin lymphoma subtypes: A pooled analysis.
    Boyle T; Kleinstern G; Bracci PM; Cerhan JR; Benavente Y; Casabonne D; Chiu BC; Habermann TM; Holly EA; Liebow M; Norman A; Paltiel O; Robinson D; Rothman N; Abu Seir R; Slager SL; Villeneuve PJ; Wang SS; Weisenburger DD; Spinelli JJ
    Int J Cancer; 2023 Feb; 152(3):396-407. PubMed ID: 36054546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes.
    Moubadder L; McCullough LE; Flowers CR; Koff JL
    Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):1844-1855. PubMed ID: 32727723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of non-Hodgkin lymphoma.
    Grulich AE; Vajdic CM
    Pathology; 2005 Dec; 37(6):409-19. PubMed ID: 16373224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.
    Smedby KE; Hjalgrim H
    Semin Cancer Biol; 2011 Nov; 21(5):293-8. PubMed ID: 21945518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and etiology of non-Hodgkin lymphoma--a review.
    Ekström-Smedby K
    Acta Oncol; 2006; 45(3):258-71. PubMed ID: 16644568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular genetics of non-Hodgkin lymphoma: Diagnostic and prognostic implications.
    Pratap S; Scordino TS
    Exp Mol Pathol; 2019 Feb; 106():44-51. PubMed ID: 30465756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.
    Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
    Br J Haematol; 2016 Mar; 172(5):699-708. PubMed ID: 26684877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
    Porcu P; Nichols CR
    Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.